Autoimmune diseases, including inflammatory bowel disease, multiple sclerosis and
rheumatoid arthritis, have distinct clinical presentations but share underlying patterns of gut …

The gut microbiota (GM) is defined as the community of microorganisms (bacteria, archaea,
fungi, viruses) colonizing the gastrointestinal tract. GM regulates various metabolic pathways …

Depression is one of the most poorly understood diseases due to its elusive pathogenesis.
There is an urgency to identify molecular and biological mechanisms underlying depression …

Abstract Purpose of Review The association between plasma Trimethylamine N-Oxide
(TMAO), diet and risk for cardiovascular disease (CVD) is still not fully understood. While …

Trimethylamine-N-oxide (TMAO) is generated in a microbial-mammalian co-metabolic
pathway mainly from the digestion of meat-containing food and dietary quaternary amines …

Abstract Background Trimethylamine N-oxide (TMAO) is a metabolite that has attracted
attention due to its positive association with several chronic non-communicable diseases …

Gut microbiota dysbiosis is a common feature in colorectal cancer (CRC) and inflammatory
bowel diseases (IBD). Adoption of the Mediterranean diet (MD) has been proposed as a …

Context Cardiovascular benefits of empagliflozin in patients with type 2 diabetes mellitus
(T2DM) have been reported; however, the underlying mechanism remains unknown …

The first publication demonstrating that major depressive disorder (MDD) is associated with
alterations in the gut microbiota appeared in 2008 (Maes et al., 2008). The purpose of the …

Cardiometabolic disease comprises cardiovascular and metabolic dysfunction and
underlies the leading causes of morbidity and mortality, both within the United States and …